University of Freiburg-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

1992

  1. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial

    Circulation, Vol. 86, Núm. 1, pp. 100-110